Newsroom

Sorted by: Latest

-

Valmont Board Declares Quarterly Dividend

OMAHA, Neb.--(BUSINESS WIRE)--Valmont® Industries, Inc. (NYSE: VMI), a global leader that provides products and solutions to support vital infrastructure and advance agricultural productivity, today announced that its Board of Directors has declared a quarterly dividend of $0.77 per share payable on July 15, 2026, to shareholders of record on June 26, 2026. The dividend indicates an annual rate of $3.08 per share. About Valmont Industries, Inc. For more than 80 years, Valmont has been a global...
-

QIAGEN meldet vorläufige Ergebnisse für das erste Quartal 2026: Bereinigter Gewinn je Aktie entspricht bei gemischten Umsatztrends den Erwartungen; Jahresprognose 2026 aktualisiert

Venlo, Niederlande--(BUSINESS WIRE)--QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) hat heute die vorläufigen Ergebnisse für das erste Quartal 2026 bekannt gegeben. Das Unternehmen verzeichnete weiterhin eine starke Profitabilität mit einem bereinigten verwässerten Gewinn je Aktie, der den Erwartungen entsprach. Die Umsatzentwicklung war gemischt, wobei geringere Umsätze bei QuantiFERON und eine zurückhaltende Nachfrage seitens der US-Kunden im Bereich Life Sciences das solide Wachstum...
-

COPT Defense Reports First Quarter 2026 Results

COLUMBIA, Md.--(BUSINESS WIRE)--COPT Defense Properties (“COPT Defense” or the “Company”) (NYSE: CDP) announced results for the first quarter ended March 31, 2026. Management Comments Stephen E. Budorick, COPT Defense’s President & Chief Executive Officer, commented, “We achieved solid results in the first quarter and our performance is tracking on all aspects of our full year plan. FFO per share exceeded the midpoint of our guidance range by $0.01. Based on this outperformance, and our for...
-

Mundipharma gibt positive vorläufige Ergebnisse der Phase-III-Studie ReSPECT bekannt, in der ▼ REZZAYO® (Rezafungin) zur Prophylaxe invasiver Pilzerkrankungen nach einer allogenen hämatopoetischen Stammzelltransplantation untersucht wurde

CAMBRIDGE, Großbritannien--(BUSINESS WIRE)--Mundipharma veröffentlichte heute positive Topline-Ergebnisse aus der globalen klinischen Phase-III-Studie ReSPECT, in der REZZAYO® (Rezafunginacetat) zur Prophylaxe invasiver Pilzerkrankungen (IFDs) bei erwachsenen Patienten untersucht wurde, die eine allogene hämatopoetische Stammzelltransplantation (HSCT) erhalten. Die ReSPECT-Phase-III-Studie ist eine der größten multizentrischen, randomisierten Doppelblindstudien im Bereich der Antimykotika und u...
-

QIAGEN reports preliminary Q1 2026 results: achieves adjusted EPS outlook with mixed sales trends; updates full-year 2026 outlook

VENLO, the Netherlands--(BUSINESS WIRE)--QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced preliminary results for the first quarter of 2026, continuing to deliver strong profitability as adjusted diluted earnings per share (EPS) achieved the outlook. Sales trends were mixed, as lower QuantiFERON sales and cautious U.S. Life Sciences customer demand offset solid growth in other areas of the portfolio. For Q1 2026, preliminary net sales were $492 million, up 2% on a reporte...
-

CACI Achieves Amazon Web Services Managed Service Provider Status for its Secure, Compliant Hybrid Cloud Solutions

RESTON, Va.--(BUSINESS WIRE)--CACI International Inc (NYSE: CACI) announced today that it has achieved Amazon Web Services (AWS) Managed Service Provider (MSP) status. This latest recognition adds to CACI’s current arsenal of technical and business accomplishments achieved through precise hybrid cloud execution and robust qualifications, uniting edge-to-cloud delivery with audited 24/7 operations for mission workloads. “Transforming how our customers work takes bold, forward leaning investments...
-

Cannae Holdings, Inc. Announces First Quarter 2026 Earnings Release Date and Conference Call

LAS VEGAS--(BUSINESS WIRE)--Cannae Holdings, Inc. (NYSE: CNNE) (“Cannae” or the “Company”) today announced that the Company will release its First Quarter 2026 financial results after the market close on Monday, May 11, 2026. The Company will also hold a conference call to discuss its financial results at 5:00 pm (Eastern Time) on the same day. The conference call can be accessed by dialing 1-800-579-2543 (domestic) or 1-785-424-1789 (international) and asking for the Cannae Holdings First Quar...
-

MFS Releases Closed-End Fund Income Distribution Sources for Certain Funds

BOSTON--(BUSINESS WIRE)--MFS releases distribution income sources for certain closed end funds for April 2026...
-

AvalonBay Communities, Inc. Provides Q1 2026 Results, Q2 2026 Guidance, Reaffirms Full Year Core FFO and FFO Outlook, Updates EPS Outlook

ARLINGTON, Va.--(BUSINESS WIRE)--AvalonBay Communities, Inc. (NYSE: AVB) (the “Company”) reported Earnings per Share – diluted (“EPS”), Funds from Operations attributable to common stockholders - diluted (“FFO”) per share and Core FFO per share (as defined in this release) for the three months ended March 31, 2026 and 2025 as detailed below.     Q1 2026   Q1 2025   % Change EPS $ 2.33   $ 1.66   40.4 % FFO per share (1) $ 2.72   $ 2.78   (2.2 )% Core FFO per share (1) $ 2.83   $ 2.83   — %    ...
-

FB Financial Corporation Announces $175 Million Common Stock Repurchase Authorization

NASHVILLE, Tenn.--(BUSINESS WIRE)--FB Financial Corporation (“the Company”) (NYSE: FBK), the parent company of FirstBank, announced today that its board of directors authorized the repurchase of up to $175 million of the Company’s outstanding common stock. The repurchase authorization will be in place until June 30, 2027, and replaces the Company’s previous authorization, which was to expire on January 31, 2027. “The board’s approval of this repurchase authorization reflects the Company’s stron...